Back to Trades
Stockwell Lynn
CEO and Exe. Chair of BoardDirector10% OwnerCIK 0001927032
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 2
- Buy transactions
- 1
- Sell transactions
- 1
- Companies
- 1
- Active
- 2025
Stockwell Lynn, CEO and Exe. Chair of Board, Director, 10% Owner, accounts for 2 disclosed filings worth $0, all concentrated in Drugs Made In America Acquisition II Corp. (DMII), active 2025. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
2 loaded
| Oct 1 | DMII Drugs Made In America Acquisition II Corp. | Stockwell Lynn | CEO and Exe. Chair of Board, Director, 10% Owner | Buy | $0 |
| Sep 24 | DMII Drugs Made In America Acquisition II Corp. | Stockwell Lynn | CEO & Exe. Chair of the Board, Director, 10% Owner | Other | $0 |
2 filings